{"id":1870,"date":"2013-07-04T15:11:07","date_gmt":"2013-07-04T15:11:07","guid":{"rendered":"\/?p=1870"},"modified":"2013-07-04T15:11:38","modified_gmt":"2013-07-04T15:11:38","slug":"implant-sciences-corp-otcmktsimsc-with-a-modest-gain","status":"publish","type":"post","link":"\/articles\/implant-sciences-corp-otcmktsimsc-with-a-modest-gain\/","title":{"rendered":"Implant Sciences Corp. (OTCMKTS:IMSC) With A Modest Gain"},"content":{"rendered":"

\"IMSCchart.png\"In the pre-holiday session investors showed some serious interest in the stock of Implant Sciences Corp. (OTCMKTS:IMSC<\/a>). In just the shot span of active trading more than 300 thousand shares changed owners and the ticker rose by 4%. Admittedly the gain isn’t very impressive but at the current price levels of the stock it means that IMSC<\/a> added 5 cents to their value and closed at $1.24. We will see if the gathered momentum carries over to tomorrows market and if the stock climbs even higher. <\/p>\n

IMSC<\/a> provide Explosive Trace Detection technologies through their two products QS-B220 and QS-h150. The main difference between them is that the latter is capable of detection without making direct contact with the target. Back in January IMSC<\/a> got approval on their products by the US Transportation Security Administration but curiously enough the main market they have been expanding their activities has been China.<\/p>\n

According to the CEO, the company has sold 800 hundred of their quantum sniffers for a total of $25-30 million worth in revenues. And they desperately need those kinds of funds in their balance sheet. Despite having success in attracting various buyers IMSC<\/a> finished the quarter ending March 31 with the following results:<\/p>\n